Xinyi Dai

Dr. Xinyi Dai


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2012 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
XDXinyi Dai
Xinyi Dai
WNWei Nie
Wei Nie
YWYong-Chun Wang
Yong-Chun Wang
YSYi Shen
Yi Shen
YLYan Li
Yan Li
SGShu-Jie Gan
Shu-Jie Gan

5 September 2020 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
TCTao Cheng
Tao Cheng
ZZZhiheng Zhang
Zhiheng Zhang
HSHua Shen
Hua Shen
ZJZiying Jian
Ziying Jian
JLJunsheng Li
Junsheng Li
XDXinyi Dai
Xinyi Dai
Background: Pancreatic adenocarcinoma (PDAC) is one of the most fatal malignancies. Surgical resection supplemented by chemotherapy remains the major therapeutic regimen, but with unavoidable resistance and systemic toxic reaction. Curcumin is a known safe natural compound that can effectively eliminate pancreatic adenocarcinoma cells in vitro, making it a promising candidate for substitution in subsequent chemotherapy. However, due to its extremely low bioavailability caused by its insolubility and circular elimination, curcumin had an unexpectedly modest therapeutic effect in clinical trials. Results: Here, we electrospun curcumin/gelatin-blended nanofibrous mat to largely improve curcumin’s bioavailability by local controlled-release. With characterization by scanning electron microscopy, fluorescence microscopy, Fourier transform infrared spectroscopy, X-ray diffraction and high-performance liquid chromatography, it was revealed that curcumin was uniformly dispersed in the fiber of the mats with nanoscopic dimensions and could be continuously released into the surrounding medium for days. The cancer inhibitory effects of nano-curcumin and underlying mechanisms were further explored by assays using pancreatic adenocarcinoma cell and experiments using xenograft model. The results showed the released nano-curcumin could effectively inhibit pancreatic adenocarcinoma cell proliferation not only in vitro, but more importantly in vivo. This cytotoxic effect of nano-curcumin against pancreatic adenocarcinoma was achieved through provoking the production of intracellular reactive oxygen species and activating endoplasmic reticulum stress, which leads to enhanced cell apoptosis via decreased phosphorylation of signal transducer and activator of transcription 3. Conclusions: Clinically, curcumin/gelatin-blended nanofibrous mat could be a promising, secure, efficient and affordable substitutional agent for the elimination of residual cancer cells after tumor resection. Moreover, our strategy to obtain curcumin released from nanofibrous mat may provide a universally applicable approach for the study of the therapeutic effects and molecular mechanisms of other potential medicines with low bioavailability.

12 November 2024 in Composites Part B: Engineering
Verified
Journal Article
Closed access
WNWEI NIE
WEI NIE
EMEric J. Marrotte
Eric J. Marrotte
RXRongyuan Xie
Rongyuan Xie
HMHans-Günther Machens
Hans-Günther Machens
Arndt SchillingArndt Schilling
Arndt Schilling
XDXinyi Dai
Xinyi Dai

19 July 2024 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
XDXinyi Dai
Xinyi Dai
WNWei Nie
Wei Nie
CDChuanyou Duan
Chuanyou Duan
YSYi Shen
Yi Shen
The treatment of aseptic inflammation has always been a clinical challenge. At present, non-steroidal drug-loaded microspheres have been widely used in the treatment of aseptic inflammation due to their excellent injectable and sustained release capabilities. In this study, ketoprofen-loaded shellac microspheres (Keto-SLAC) were prepared by electrospray. Alterations of Keto-SLAC morphology was observed in response to changed shellac concentration in ethanol solution through electrospray. Further examination revealed that ketoprofen presented as amorphous solid dispersion in the shellac microspheres. Most importantly, it was also shown that ketoprofen can be slowly released from the shellac matrix for up to 3 weeks. In vitro cell experiments verified that the microspheres had favorable cell compatibility. We therefore proposed that the prepared microspheres, being readily available in use in a variety of clinical settings through topical application, have promising therapeutic potential for the treatment of aseptic inflammation.